CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages-Reference-Cited by-同舟云学术

CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages

Published:2018-03 Issue: Volume:88 Page:131-138
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Samudra Anushka N.,Dwyer Karen M.,Selan Carly,Freddi Susanna,Murray-Segal Lisa,Nikpour Mandana,Hickey Michael J.^ORCID,Peter Karlheinz,Robson Simon C.,Sashindranath Maithili^ORCID,Cowan Peter J.,Nandurkar Harshal H.

Funder

NHMRC

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Current treatment of antiphospholipid syndrome: lights and shadows;Espinosa;Nat. Rev. Rheumatol.,2015

2. The pathogenesis of the antiphospholipid syndrome;Giannakopoulos;N. Engl. J. Med.,2013

3. Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome;Brock;Birth Defects Res. C Embryo Today,2015

4. Treatment of thrombotic antiphospholipid syndrome: the rationale of current management-an insight into future approaches;Chighizola;J. Immunol. Res.,2015

5. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep;Zhou;Blood,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of antiphospholipid antibody syndrome;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Exosomal miR-146a-5p derived from human umbilical cord mesenchymal stem cells can alleviate antiphospholipid antibody-induced trophoblast injury and placental dysfunction by regulating the TRAF6/NF-κB axis;Journal of Nanobiotechnology;2023-11-13

3. The evaluation of CD39, CD73, and HIF-1 α expression besides their related miRNAs in PBMCs of women with recurrent pregnancy loss;Journal of Reproductive Immunology;2023-03

4. Pathophysiology of Placenta in Antiphospholipid Syndrome;Physiologia;2022-08-17

5. CD39 in the development and progression of pulmonary arterial hypertension;Purinergic Signalling;2022-08-10